Tirzepatide is a synthetic 39-amino acid peptide that functions as a dual agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual incretin mechanism distinguishes tirzepatide from monoagonist GLP-1 receptor agonists and has made it a subject of significant interest in metabolic disease research.
In preclinical and clinical research settings, tirzepatide has demonstrated the capacity to enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, slow gastric emptying, and reduce appetite-related signalling. These combined actions have positioned it as a highly investigated compound in studies related to type 2 diabetes, obesity, and broader metabolic syndrome research.
This Peptician 15mg vial is supplied as a lyophilised powder of high purity (>98%), suitable for in vitro and controlled in vivo research applications. Each batch is independently verified for identity and purity.
Storage: Store lyophilised product at -20°C. Once reconstituted, store at 4°C and use within 30 days. Protect from light and repeated freeze-thaw cycles.
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4813.5 g/mol
Purity
>98%
CAS Number
2023788-19-2
Form
Lyophilised Powder
Research Applications
Metabolic syndrome research, Type 2 diabetes modelling, Obesity and adiposity studies, GIP receptor pharmacology, GLP-1 receptor pharmacology, Appetite and energy homeostasis research
For research purposes only. Not for human use. This product is intended solely for in vitro and preclinical research applications by qualified professionals.
Reviews
There are no reviews yet.